Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

6th October 2010: Wednesday in New Delhi, patients and activists stage a DIE-IN to protest at talks today between the European Union and the Indian government over a free trade agreement that could end production of life-saving affordable medicines for millions in need in developing countries. Photo credit: Suraj Mishra
Press release
Press release |
12 March 2024
Intellectual property and trade
SwitzerlandIndia

MSF response to signing of EFTA-India trade agreement

2 min
A close-up photo shows pills in the hand of an MDR TB patient taking his Direct Observation Treatment Short Course (DOTs) medication at the Nhlangano TB Ward supported by MSF. Photo credit: Giorgos Moutafis
Press release
Press release |
29 February 2024
Intellectual property and trade

EU must drop all intellectual property provisions that go beyond WTO requirements in trade negotiations with India, as recommended in today’s SIA report

5 min
Thousands of demonstrators took to the streets in Delhi once again on 2 March 2011, in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines.Thousands of demonstrators took to the streets in Delhi once again on 2 March in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines. Photo credit: Mudit Mathur
Press release
Press release |
15 February 2024
Intellectual property and trade
EuropeIndia

MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions

2 min
Thousands of demonstrators took to the streets in Delhi once again on 2 March, 2011, in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines. Photo credit: Mudit Mathur
Press release
Press release |
14 February 2024
Intellectual property and trade
India

Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is

5 min
Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health. Photo credit: MSF/Martim Gray Pereira
Press release
Press release |
06 February 2024
HIV/AIDS

Colombia takes significant next step to expand people’s access to affordable HIV treatment, and moves forward with compulsory license for HIV medicine dolutegravir

5 min
European Parliament Strasbourg Hemicycle Copyright by David Iliff. License: CC BY-SA 3.0
Press release
Press release |
16 January 2024
Intellectual property and trade

MSF calls on European Parliament and Council to lift export prohibition in Union compulsory license

3 min
Goma, North Kivu province in the Democratic Republic of Congo (DRC), multi-antigen vaccination campaign. Photo credit: MSF/Alexandre Marcou
Press release
Press release |
04 December 2023
Vaccines

Gavi Board must make catch-up vaccination a priority when allocating leftover COVAX money

5 min
Dr Samsuddin Khan performs physical exam of Deepak Sabhash Shegar, a person living with DR-TB, at MSF DR-TB clinic, Chembur, Mumbai, India, 2022 Photo credit: Prem Hessenkamp
Press release
Press release |
15 November 2023
Tuberculosis

Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

6 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury